143 related articles for article (PubMed ID: 7672107)
1. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids.
Soto C; Castaño EM; Prelli F; Kumar RA; Baumann M
FEBS Lett; 1995 Sep; 371(2):110-4. PubMed ID: 7672107
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L. Implications for amyloidogenesis and Alzheimer's disease.
Castaño EM; Prelli F; Pras M; Frangione B
J Biol Chem; 1995 Jul; 270(29):17610-5. PubMed ID: 7615568
[TBL] [Abstract][Full Text] [Related]
3. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
[TBL] [Abstract][Full Text] [Related]
4. Peptides corresponding to gelsolin derived amyloid of the finnish type (AGelFIN) adopt two distinct forms in solution of which only one can polymerize into amyloid fibrils and form complexes with apoE.
Fadika GO; Baumann M
Amyloid; 2002 Jun; 9(2):75-82. PubMed ID: 12440479
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro.
Soto C; Golabek A; Wisniewski T; Castaño EM
Neuroreport; 1996 Feb; 7(3):721-5. PubMed ID: 8733730
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E includes a binding site which is recognized by several amyloidogenic polypeptides.
Baumann MH; Kallijärvi J; Lankinen H; Soto C; Haltia M
Biochem J; 2000 Jul; 349(Pt 1):77-84. PubMed ID: 10861213
[TBL] [Abstract][Full Text] [Related]
7. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides.
Maury CP; Nurmiaho-Lassila EL; Rossi H
Lab Invest; 1994 Apr; 70(4):558-64. PubMed ID: 8176895
[TBL] [Abstract][Full Text] [Related]
8. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
9. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils.
Ray I; Chauhan A; Wegiel J; Chauhan VP
Brain Res; 2000 Jan; 853(2):344-51. PubMed ID: 10640633
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling of apoE in complexes with Alzheimer's amyloid-β fibrils from human brain suggests a structural basis for apolipoprotein co-deposition with amyloids.
Lewkowicz E; Nakamura MN; Rynkiewicz MJ; Gursky O
Cell Mol Life Sci; 2023 Nov; 80(12):376. PubMed ID: 38010414
[TBL] [Abstract][Full Text] [Related]
11. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.
Chargé SB; Esiri MM; Bethune CA; Hansen BC; Clark A
J Pathol; 1996 Aug; 179(4):443-7. PubMed ID: 8869295
[TBL] [Abstract][Full Text] [Related]
13. Fibrillogenesis in gelsolin-related familial amyloidosis.
Maury CP; Nurmiaho-Lassila EL; Boysen G; Liljeström M
Amyloid; 2003 Aug; 10 Suppl 1():21-5. PubMed ID: 14640038
[TBL] [Abstract][Full Text] [Related]
14. Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice.
Kindy MS; Rader DJ
Am J Pathol; 1998 May; 152(5):1387-95. PubMed ID: 9588907
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E and amyloidogenesis.
Frangione B; Castaño EM; Wisniewski T; Ghiso J; Prelli F; Vidal R
Ciba Found Symp; 1996; 199():132-41; discussion 141-5. PubMed ID: 8915608
[TBL] [Abstract][Full Text] [Related]
16. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro.
Wisniewski T; Castaño EM; Golabek A; Vogel T; Frangione B
Am J Pathol; 1994 Nov; 145(5):1030-5. PubMed ID: 7977635
[TBL] [Abstract][Full Text] [Related]
17. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E and apolipoprotein A-1 knock-out mice readily develop amyloid A protein amyloidosis.
Elliott-Bryant R; Cathcart ES
Clin Immunol Immunopathol; 1997 Oct; 85(1):104-8. PubMed ID: 9325076
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of amyloid proteins.
Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
[TBL] [Abstract][Full Text] [Related]
20. Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E.
Wood SJ; Chan W; Wetzel R
Biochemistry; 1996 Sep; 35(38):12623-8. PubMed ID: 8823200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
